-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OsDaNRytAv+iwwoc8G6tKmoALB+78MiS5f2tOEnEm3KdrWjACHIdBx4+j2lzCqkU /TkUJha/nic0CZxpsnGCkg== 0001408617-09-000015.txt : 20090122 0001408617-09-000015.hdr.sgml : 20090122 20090122173057 ACCESSION NUMBER: 0001408617-09-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090120 FILED AS OF DATE: 20090122 DATE AS OF CHANGE: 20090122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nader Francois CENTRAL INDEX KEY: 0001365343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 09539931 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-01-20 0000890465 NPS PHARMACEUTICALS INC NPSP 0001365343 Nader Francois 550 HILLS DRIVE BEDMINSTER NJ 07921 1 1 0 0 President, CEO and Director Stock Option 5.71 2009-01-20 4 A 0 120000 0 A 2019-01-20 Common Stock 120000 120000 D Stock Option 5.71 2009-01-20 4 A 0 231563 0 A 2019-01-20 Common Stock 231563 231563 D Represents options granted to the Reporting Person under the Issuer's 1998 Stock Option Plan. Options vest and become exercisable 25% on the first anniversary of the date of grant and 6.25% every three months thereafter. Represents options granted to the Reporting Person under the Issuer's 1998 Stock Option Plan. Options vest and become exercisable 50% on the second anniversary of the date of grant and 50% on the third anniversary of the date of grant, with the actual number of options vesting on such dates determined based on the performance of the Issuer's common stock relative to the performance of stock comprising a selected market index. Andrew Rackear as Attorney-in-Fact 2009-01-22 -----END PRIVACY-ENHANCED MESSAGE-----